Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
Sawsan Aboul‐Fotouh, Ahmed N. Mahmoud, Esraa M. Elnahas, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 11
Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches
Seyed Mohammadmahdi Meybodi, Venus Shahabi Rabori, Darya Salkhorde, et al.
Cytokine (2024) Vol. 184, pp. 156794-156794
Closed Access | Times Cited: 4
Advancements in the development of antivirals against SARS-Coronavirus
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
The HEARRT-C Score: Is Aspirin Protective in COVID-19 Patients? A Single-Centre Retrospective Study
Zeynep Kumral, Ali Cantürk, Ahmet Anıl Başkurt, et al.
COVID (2025) Vol. 5, Iss. 2, pp. 21-21
Open Access
Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis
Igor Resendes Barbosa, Mayara Alves Amorim, Vitor Hélio de Souza Oliveira, et al.
ChemMedChem (2025)
Closed Access
Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-κB Pathway
Sepideh Barzin Tond, Sara Abolghasemi, Seyyed Hossein Khatami, et al.
Journal of Dietary Supplements (2025), pp. 1-17
Closed Access
A concise review on influenza
Pratibha L. Ayanar, Simran M. Jamadar, Shweta R. Bharati, et al.
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 3, pp. 1355-1361
Open Access
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants
Yun-Jong Park, Wojciech Jankowski, Nicholas C. Hurst, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Open Access
Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation
Padmika Madushanka Wadanambi, Uthpali Mannapperuma, Nimanthi Jayathilaka
Chemical Papers (2025)
Closed Access
Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2
Paula A. Velásquez-Bedoya, María I. Zapata-Cardona, Laura Milena Monsalve-Escudero, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1419-1419
Open Access
Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors
Elvis Awuni
Journal of Chemical Research (2025) Vol. 49, Iss. 2
Open Access
Dynamic Gene Attention Focus (DyGAF): Enhancing Biomarker Identification Through Dual-Model Attention Networks
Md Khairul Islam, Himanshu Wagh, Hairong Wei
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Antiviral properties of milk proteins and peptides against SARS-COV-2: A review
Parminder Singh, Janak Dhakal, Pavan Kumar
Journal of Functional Foods (2024) Vol. 117, pp. 106237-106237
Open Access | Times Cited: 2
Harnessing immunity: Immunomodulatory therapies in COVID-19
Tsvetelina Velikova, Hristo Valkov, A Aleksandrova, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
An approach for detecting the severity levels of COVID-19 and associated features in district Gujranwala, Pakistan

Biomedical Letters (2024) Vol. 10, Iss. 1, pp. 42-50
Closed Access | Times Cited: 1
Competitive Interaction of the SGFRKMAF Peptide with 3CLpro Dimerization Intermediates: A Brownian Dynamics Investigation
Karim M. ElSawy
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 30, pp. 7313-7321
Closed Access | Times Cited: 1
Assessing the Utility of Prediction Scores PAINT, ISARIC4C, CHIS, and COVID-GRAM at Admission and Seven Days after Symptom Onset for COVID-19 Mortality
Alina Doina Tănase, Oktrian FNU, Dan-Mihai Cristescu, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 966-966
Open Access | Times Cited: 1
Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice
Sabrina Mendes, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 1
Convalescent Plasma for Critically-ill Covid-19 Patients
Adel A. Aljatham, Waleed T. Hashim, Mohamad A. Almashiakhi, et al.
Research Square (Research Square) (2024)
Open Access
Pathway Circuit Mapping for Drug Repurposing: CoV-DrugX Tool Sheds Light on Therapeutic Opportunities
Shreya Aggarwal, Apurva Rustagi, Agrima Chopra, et al.
(2024)
Open Access
Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic
Radu Lefter, Prairna Balyan, Ioana-Miruna Balmuș, et al.
Microbiology Research (2024) Vol. 15, Iss. 2, pp. 525-549
Open Access
Recombinant ACE2 - Opportunities and Challenges in COVID-19 Treatment
Mandeep Kaur, Rahul Sandhu, Akriti Aggarwal
Infectious Disorders - Drug Targets (2024) Vol. 25, Iss. 1
Open Access
In silico studies of phycobilins as potential candidates for inhibitors of viral proteins associated with COVID-19
Vesna Jovanović, Milan Nikolić, Srđan Đ. Stojanović
Journal of the Serbian Chemical Society (2024) Vol. 89, Iss. 7-8, pp. 997-1009
Open Access
Investigating the Impact of COVID-19 on the Incidence of Cardiovascular Diseases: A Cross-sectional Study
Ehsan Goroei Sardu, Rasoul Raesi, Vahid Pooladvand, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access
Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors
Przemysław Biegański, Monika Gazecka, Rafał Nowak, et al.
Organometallics (2024) Vol. 43, Iss. 20, pp. 2505-2519
Open Access
Page 1 - Next Page

Scroll to top